These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3751255)

  • 21. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 23. Should mild hypertension be treated? An attempted meta-analysis of the clinical trials.
    Sacks HS; Chalmers TC; Berk AA; Reitman D
    Mt Sinai J Med; 1985 Apr; 52(4):265-70. PubMed ID: 3873604
    [No Abstract]   [Full Text] [Related]  

  • 24. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
    Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
    Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Better prognosis in hypertension and left ventricular hypertrophy. LIFE Study sets new standard].
    MMW Fortschr Med; 2002 May; 144(20):60-1. PubMed ID: 12119887
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of isosorbide in the treatment of severe, uncontrolled hypertension.
    Fontanet H; García JC; del Río J; Martínez-Maldonado M
    Arch Intern Med; 1987 Mar; 147(3):426-8. PubMed ID: 3827416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What are the consequences of the LIFE Study for general practice].
    Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 32. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of mild and moderate arterial hypertension with enalapril. A multicenter study of enap and enap-HL in Russia].
    Ol'binskaia LI
    Ter Arkh; 1997; 69(8):86-8. PubMed ID: 9381405
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire.
    Olsen MH; Mallion JM; Rahn KH; Erdine S; Viigimaa M; Laurent S; Agabiti-Rosei E; Mancia G; Schmieder RE; Cifkova R; Dominiczak A; Kjeldsen SE; Redon J; Zanchetti A; Nilsson P; Narkiewicz K;
    J Hypertens; 2010 Jul; 28(7):1593-4. PubMed ID: 20574253
    [No Abstract]   [Full Text] [Related]  

  • 37. The veterans trial and sequelae.
    Freis ED
    Br J Clin Pharmacol; 1982 Jan; 13(1):67-72. PubMed ID: 7039648
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary arterial hypertension in the elderly].
    Halawa B
    Pol Tyg Lek; 1988 Feb; 43(9):267-71. PubMed ID: 3405899
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of arterial hypertension in 1987].
    Larochelle P; Cusson JR
    Union Med Can; 1988 Feb; 117(1):101-6. PubMed ID: 3376336
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hypertension in advanced age].
    Kurz RW; Tragl KH
    Fortschr Med; 1987 Jul; 105(20):391-3. PubMed ID: 3610009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.